Early- and mid-term outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20%: A comparative analysis between different risk strata

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 1, 2012, Pages 132-140

  Tamburino, Corrado ^a,b   Barbanti, Marco ^a   Capodanno, Davide ^a   Sarkar, Kunal ^a   Cammalleri, Valeria ^a   Scarabelli, Marilena ^a   Mulè, Massimiliano ^a   Immè, Sebastiano ^a   Aruta, Patrizia ^a   Ussia, Gian Paolo ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b Excellence Through Newest Advances ETNA Foundation   (Italy)

Author keywords

aortic stenosis; EuroSCORE; high risk; TAVI

Indexed keywords

AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; EUROSCORE; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; MALE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OPEN HEART SURGERY; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; RISK ASSESSMENT; STROKE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

EID: 83655195180     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23100     Document Type: Article

References (25)

1. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A,. Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268. (Pubitemid 46276943)
2. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S,; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
3. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, Devarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, Delarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E,. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk acute and late outcomes of the multicenter canadian experience. J Am Coll Cardiol 2010; 55: 1080-1090.
4. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O,. Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) Registry. A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122: 62-69.
5. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gueret P,; on behalf of the FRANCE Registry Investigators. Transcatheter aortic valve implantation: Early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011; 32: 191-197.
6. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J,; on behalf of the German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: First results from a multi-centre real-world registry. Eur Heart J 2011; 32: 198-204.
7. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP,. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011 123: 299-308.
8. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Pièrard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Von Segesser LK, Walther T,. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008; 11: 1463-1470. (Pubitemid 351806497)
9. Roques F, Nashef SA, Michel P,; EuroSCORE study group. Risk factors for early mortality after valve surgery in Europe in the 1990s: Lessons from the EuroSCORE pilot program. J Heart Valve Dis 2001; 10: 572-577.
10. Shroyer AL, Coombs LP, Peterson E, et al., The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003; 75: 1856-1865. (Pubitemid 36677229)
11. Tamburino C, Capodanno D, Mulè M, Scarabelli M, Cammalleri V, Barbanti M, Calafiore A, Ussia GP,. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol 2009; 21: 93-98.
12. Fraccaro C, Napodano M, Tarantini G, Gasparetto V, Gerosa G, Bianco R, Bonato R, Pittarello D, Isabella G, Iliceto S, Ramondo A,. Expanding the eligibility for transcatheter aortic valve implantation: The trans-subclavian retrograde approach using the III generation corevalve revalving system. JACC Cardiovasc Interv 2009; 2: 828-833.
13. Ussia GP, Scarabelli M, Mulè M, Barbanti M, Cammalleri V, Immè S, Aruta P, Pistritto AM, Carbonaro A, Deste W, Sciuto P, Licciardello G, Calvi V, Tamburino C,. Post procedural management of patients after transcatheter aortic valve implantation procedure with self-expanding bioprosthesis. Catheter Cardiovasc Interv 2010; 76: 757-766.
14. Ussia GP, Barbanti M, Immè S, Scarabelli M, Mulè M, Cammalleri V, Aruta P, Pistritto AM, Capodanno D, Deste W, Di Pasqua MC, Tamburino C,. Management of implant failure during transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 76: 440-449.
15. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP,. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123: 299-308.
16. Collart F, Feier H, Kerbaul F, et al. Valvular surgery in octogenarians: Operative risks factors, evaluation of Euroscore and long term results. Eur J Cardiothorac Surg 2005; 27: 276-280. (Pubitemid 40193137)
17. Grossi EA, Schwartz CF, Yu PJ, Jorde UP, Crooke GA, Grau JB, Ribakove GH, Baumann FG, Ursumanno P, Culliford AT, Colvin SB, Galloway AC,. High-risk aortic valve replacement: Are the outcomes as bad as predicted? Ann Thorac Surg 2008; 85: 102-106.
18. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ,. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008; 135: 180-187.
19. Osswald BR, Gegouskov V, Badowski-Zyla D, Tochtermann U, Thomas G, Hagl S, Blackstone EH,. Overestimation of aortic valve replacement risk by EuroSCORE: Implications for percutaneous valve replacement. Eur Heart J 2009; 30: 74-80.
20. Leontyev S, Walther T, Borger MA, Lehmann S, Funkat AK, Rastan A, Kempfert J, Falk V, Mohr FW., Aortic valve replacement in octogenarians: Utility of risk stratification with EuroSCORE. Ann Thorac Surg 2009; 87: 1440-1445.
21. Toumpoulis IK, Anagnostopoulos CE, Toumpoulis SK, DeRose JJ Jr, Swistel DG,. EuroSCORE predicts long-term mortality after heart valve surgery. Ann Thorac Surg 2005; 79: 1902-1908. (Pubitemid 40804160)
22. Michel P, Roques F, Nashef SA,. Logistic or additive EuroSCORE for high-risk patients? Eur J Cardiothorac Surg 2003; 23: 684-687. (Pubitemid 36566559)
23. Piazza N, Wenaweser P, van Gameren M, Pilgrim T, Tsikas A, Otten A, Nuis R, Onuma Y, Cheng JM, Kappetein AP, Boersma E, Juni P, de Jaegere P, Windecker S, Serruys PW,. Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system-A Bern-Rotterdam Study. Am Heart J 2010; 159: 323-329.
24. Piazza N, van Gameren M, Jüni P, Wenaweser P, Carrel T, Onuma Y, Gahl B, Hellige G, Otten A, Kappetein AP, Takkenberg JJ, van Domburg R, de Jaegere P, Serruys PW, Windecker S,. A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: A two-centre study. EuroIntervention 2009; 5: 580-588.
25. Walther T, Schuler G, Borger MA, Kempfert J, Seeburger J, Rückert Y, Ender J, Linke A, Scholz M, Falk V, Mohr FW,. Transapical aortic valve implantation in 100 consecutive patients: Comparison to propensity-matched conventional aortic valve replacement. Eur Heart J 2010; 31: 1398-1403.